Understanding the genetic basis of susceptibility and severity of infectious diseases Flashcards

1
Q

Why do we undertake genetic studies of infectious diseases?

A

Identify fundamental pathways causing susceptibility
Identify those susceptible
Identify key components of pathophysiology
Explain individual differences in clinical presentation or outcome
Identify targets for therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is HapMap?

A

Program to chart genetic variation within the human genome- an international effort to construct a map of the patterns of SNOs (single nucleotide and other variants in genome) that occur across populations in Africa, Asia and United states

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What advances in technology for genome sequencing have there been?

A

High throughput sequencing
SNP microarrays of 500,000 to 1 million SNPs
RNA expression arrays
Bioinformatic methods for large data set
Extensive databases on genes and function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How common is infection with mycobacterial TB?

A

Very common- 60% of population of Africa may be infected by mycobacterial TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why do only a small percentage of those infected with mycobacterial TB go on to develop disease?

A

The outcome is affected by bacterial, environmental and genetic factors which lead to either a successful immune response or disease- unsuccessful immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the concept of homozygosity by descent?

A

If a rare recessive defect is introduced into a population by a common ancestor, the affected patients will be homozygous not only for the abnormal gene but also for genes in the vicinity of the defect (occurs with inbreeding)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How can you identify the chromosomal location of abnormal genes in homozygosity by descent?

A

Searching for regions of the genome for which all the affected individuals are homozygous by descent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the IFN-gamma receptor and which cells express it?

A

It is expressed on all cells. It is a type II cytokine receptor coded for by a gene on chromosome 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are all mutations of IFN gamma associated with?

A

Susceptibility to mycobacteria and salmonella

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What forms of meningococcal disease are there vaccines for?

A

A and C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does infection with meningococcal disease come about?

A

It comes on very rapidly spreading from the nose into the bloodstream then other organs and the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why is meningococcal disease remarkable?

A

It is so variable- it can lead to asymptomatic bacteraemia, meningitis, septic shock or purpura fulminans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What susceptibility genes are there?

A

Control colonisation and invasion and survival in blood

More present in cases vs controls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What do severity genes do?

A

They determine the inflammatory response, extent of coagulopathy and organ failure
Same frequency in case vs controls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What causes recurrent meningococcal disease?

A

Complement deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

For what are genetic variables important in susceptibility to meningococcal disease?

A

Mannose binding lectin

17
Q

What does endotoxin trigger the release of?

A

Both plasminogen activator (PAI) and plasminogen activator inhibitor (PAI-I)

18
Q

How feasible are genome wide studies?

A

Now possible to type thousands to millions of SNPs across entire genome in each individual
Method applied to many common diseases
Requires large patient and control cohorts
High throughput technology and bioinformatics expertise has enabled this